Through a digital approach, digital cognitive rehabilitation startups aim to compensate for or improve cognitive deficits caused by lesions or illnesses that impair the brain’s optimum functioning.
FREMONT, CA: NeuroTech is a growing industry at the intersection of neuroscience and technology, bringing innovative applications, methods, products, facilities, or business models to provide scalable solutions that supports patients with neurological disorders, healthcare providers, researchers, and payers.
NeuroTech originated from a group of startups who centered or tailored their experiments and solutions to neuroscience specificities and needs as part of the HealthTech market. NeuroTech may also be described as a division of HealthTech that focuses on neuroscience and aims to solve the customer journey problems of people living with neurological disorders and HCPs.
Some NeuroTech were inspired by research and consumer demands (primarily patients and healthcare providers) and have established innovations as potential avenues for finding innovative solutions. On the other hand, others come from the tech world and prioritize the benefits of their technologies to address current neuroscience problems.
NeuroTech’s Main Focus Areas
Diagnostics and Assessment
Cognitive Assessment: Startups based on creating or providing access to Digital Neurocognitive Testing, which administers, scores, or interprets assessments of brain function and related factors relating to questions of neurologic health and illness using a computer, digital tablet, mobile device, or other digital interfaces rather than a human examiner.
Cognitive Stimulation and Rehabilitation: Through a digital approach, digital cognitive rehabilitation startups aim to compensate for or improve cognitive deficits caused by lesions or illnesses that impair the brain’s optimum functioning. Cognitive enhancement, such as cognitive training, aims to improve and maximize cognitive functions and abilities that are still present after engaging in digitally delivered activities. Startups in the field of digital therapeutics are currently attempting to achieve these goals by using digital technologies.
Monitoring and Evidence Generation
Monitoring: This involves startups that concentrate on using remote monitoring sensors, wearable devices, and mHealth (mobile health—the use of mobile devices, like smartphones and tablet computers, in medical care) applications in large-scale clinical trials and patient monitoring beyond marketing authorization of neurological diseases, and how these can be leveraged in large-scale clinical tests and patient monitoring outside marketing approval of neurological diseases.
Imaging: Focused startups that build technologies for people with or without neurological diseases that enable fast and accurate image processing with built-in machine learning and artificial intelligence.